Evidence map›Paper›PMID 16632674›Full record

ReviewArchives of disease in childhood2006

Cardiac disease and Rett syndrome.

M Acampa, F Guideri

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Archives of disease in childhood, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01777542 (Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01777542 phase2completednot on this mapstarted 2013, after this paper: background citation

Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1(Mecasermin [rDNA] Injection)

TypeinterventionalSponsorBoston Children's HospitalRan2013 to 2016Enrolled30ConditionsRett SyndromeArmsRecombinant Human Insulin Growth Factor 1 (rhIGF-1), Placebo
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Epigenetics in rare neurological diseases.Frontiers in cell and developmental biology · 2024
    Review
  10. Article
  11. Analysis of electrocardiograms in individuals with CDKL5 deficiency disorder.American journal of medical genetics. Part A · 2023
    Article
  12. Article
  13. Genetic mouse models of autism spectrum disorder present subtle heterogenous cardiac abnormalities.Autism research : official journal of the International Society for Autism Research · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

M AcampaSection of Internal Medicine, Department of Clinical Medicine and Immunological Sciences, University of Siena, Siena, Italy. M.Acampa@ao-siena.toscana.it
F Guideri
University of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rett syndrome (RS) is a neurodevelopmental disease,1 affecting approximately 1 in 10 000-15 000 females. Clinical severity of RS may vary with increasing age, following a four stage model.

Indexed as

AdolescentAdultArrhythmias, CardiacAutonomic Nervous SystemChildEchocardiographyFemaleHumansRett Syndrome

Identifiers

PMID16632674
PMCPMC2082747
OpenAlexW2001605140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.